Header Logo

Connection

Bruce Woda to Male

Back to Details
This is a "connection" page, showing publications Bruce Woda has written about Male.
Bruce Woda
Connection Strength
0.432
Male
  1. Wang SA, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, Raza A, Woda BA. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica. 2009 Jan; 94(1):29-37.
    View in: PubMed
    Score: 0.019
  2. Wang SA, Yue G, Hutchinson L, Landry ML, Hasserjian RP, Hao S, Galili N, Raza A, Woda BA. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion. Br J Haematol. 2007 Jul; 138(2):271-5.
    View in: PubMed
    Score: 0.017
  3. Jiang Z, Li C, Fischer A, Dresser K, Woda BA. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol. 2005 Feb; 123(2):231-6.
    View in: PubMed
    Score: 0.015
  4. Jiang Z, Woda BA. Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy. Adv Anat Pathol. 2004 Nov; 11(6):316-21.
    View in: PubMed
    Score: 0.014
  5. Patel SA, Gerber WK, Zheng R, Khanna S, Hutchinson L, Abel GA, Cerny J, DaSilva BA, Zhang TY, Ramanathan M, Khedr S, Selove W, Woda B, Miron PM, Higgins AW, Gerber JM. Natural history of clonal haematopoiesis seen in real-world haematology settings. Br J Haematol. 2024 May; 204(5):1844-1855.
    View in: PubMed
    Score: 0.014
  6. Saini NY, Cerny J, Furtado VF, Desmond A, Zhou Z, Raffel G, Puthawala I, Bednarik J, Shanahan L, Miron PM, Woda B, Ramanathan M, Nath R. Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based ("5 + 1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemia. Am J Hematol. 2019 02; 94(2):209-215.
    View in: PubMed
    Score: 0.010
  7. Liu Q, Cornejo KM, Cheng L, Hutchinson L, Wang M, Zhang S, Tomaszewicz K, Cosar EF, Woda BA, Jiang Z. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Am J Pathol. 2018 04; 188(4):846-852.
    View in: PubMed
    Score: 0.009
  8. Carr MI, Roderick JE, Zhang H, Woda BA, Kelliher MA, Jones SN. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice. Proc Natl Acad Sci U S A. 2016 12 27; 113(52):15024-15029.
    View in: PubMed
    Score: 0.008
  9. Magotra M, Sakhdari A, Lee PJ, Tomaszewicz K, Dresser K, Hutchinson LM, Woda BA, Chen BJ. Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways. Histopathology. 2016 Dec; 69(6):1055-1065.
    View in: PubMed
    Score: 0.008
  10. Xing W, Dresser K, Zhang R, Evens AM, Yu H, Woda BA, Chen BJ. PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications. Oncotarget. 2016 Sep 13; 7(37):59976-59986.
    View in: PubMed
    Score: 0.008
  11. Liu Q, Tomaszewicz K, Hutchinson L, Hornick JL, Woda B, Yu H. Somatic mutations in histiocytic sarcoma identified by next generation sequencing. Virchows Arch. 2016 Aug; 469(2):233-41.
    View in: PubMed
    Score: 0.008
  12. Zhou AG, Liu Y, Cyr MS, Garver J, Woda BA, Cosar EF, Hutchinson LM. Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization. Arch Pathol Lab Med. 2016 Jun; 140(6):552-9.
    View in: PubMed
    Score: 0.008
  13. Abramson JS, Feldman T, Kroll-Desrosiers AR, Muffly LS, Winer E, Flowers CR, Lansigan F, Nabhan C, Nastoupil LJ, Nath R, Goy A, Castillo JJ, Jagadeesh D, Woda B, Rosen ST, Smith SM, Evens AM. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy. Ann Oncol. 2014 Nov; 25(11):2211-2217.
    View in: PubMed
    Score: 0.007
  14. Rosenblum F, Hutchinson LM, Garver J, Woda B, Cosar E, Kurian EM. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma. Cancer Cytopathol. 2014 Nov; 122(11):810-21.
    View in: PubMed
    Score: 0.007
  15. Xiao R, Cerny J, Devitt K, Dresser K, Nath R, Ramanathan M, Rodig SJ, Chen BJ, Woda BA, Yu H. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS). Am J Surg Pathol. 2014 Jun; 38(6):776-83.
    View in: PubMed
    Score: 0.007
  16. Gao Y, Yang M, Jiang Z, Woda BA, Mercurio AM, Qin J, Huang X, Zhang F. IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma. Hum Pathol. 2014 Jun; 45(6):1184-91.
    View in: PubMed
    Score: 0.007
  17. Larson AR, Dresser KA, Zhan Q, Lezcano C, Woda BA, Yosufi B, Thompson JF, Scolyer RA, Mihm MC, Shi YG, Murphy GF, Lian CG. Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Mod Pathol. 2014 Jul; 27(7):936-44.
    View in: PubMed
    Score: 0.007
  18. Woda BA, Sullivan JL. Reactive histiocytic disorders. Am J Clin Pathol. 1993 Apr; 99(4):459-63.
    View in: PubMed
    Score: 0.006
  19. Ramanathan M, Cerny J, Yu H, Woda BA, Nath R. A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm. Haematologica. 2013 Mar; 98(3):e36.
    View in: PubMed
    Score: 0.006
  20. Banner BF, Savas L, Baker S, Woda BA. Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993; 64(4):213-20.
    View in: PubMed
    Score: 0.006
  21. Cerny J, Yu H, Ramanathan M, Raffel GD, Walsh WV, Fortier N, Shanahan L, O'Rourke E, Bednarik J, Barton B, Kroll-Desrosiers A, Hao S, Woda B, Hutchinson L, Evens AM, Rosmarin AG, Nath R. Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML). Br J Haematol. 2013 Jan; 160(2):262-6.
    View in: PubMed
    Score: 0.006
  22. Jagadeesh D, Woda BA, Draper J, Evens AM. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol. 2012 Mar; 13(1):122-36.
    View in: PubMed
    Score: 0.006
  23. Hao S, Smith TW, Chu PG, Liu Q, Ok CY, Woda BA, Lu D, Lin P, Wang SA, Dresser K, Rock KL, Jiang Z. The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma. Arch Pathol Lab Med. 2011 Aug; 135(8):1032-6.
    View in: PubMed
    Score: 0.006
  24. Shi M, Miron PM, Hutchinson L, Woda BA, Nath R, Cerny J, Yu H. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements. Hum Pathol. 2011 Oct; 42(10):1562-7.
    View in: PubMed
    Score: 0.006
  25. Tang G, Wang SA, Menon M, Dresser K, Woda BA, Hao S. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Leuk Res. 2011 Jun; 35(6):766-70.
    View in: PubMed
    Score: 0.006
  26. Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, Grant AV, Marchal CC, Hubeau M, Chapgier A, de Beaucoudrey L, Puel A, Feinberg J, Valinetz E, Janni?re L, Besse C, Boland A, Brisseau JM, Blanche S, Lortholary O, Fieschi C, Emile JF, Boisson-Dupuis S, Al-Muhsen S, Woda B, Newburger PE, Condino-Neto A, Dinauer MC, Abel L, Casanova JL. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011 Mar; 12(3):213-21.
    View in: PubMed
    Score: 0.006
  27. Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol. 2009 Aug; 40(8):1194-9.
    View in: PubMed
    Score: 0.005
  28. Lisovsky M, Dresser K, Baker S, Fisher A, Woda B, Banner B, Lauwers GY. Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study. Mod Pathol. 2009 Jul; 22(7):977-84.
    View in: PubMed
    Score: 0.005
  29. Truong F, Smith BR, Stachurski D, Cerny J, Medeiros LJ, Woda BA, Wang SA. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study. Leuk Res. 2009 Aug; 33(8):1039-46.
    View in: PubMed
    Score: 0.005
  30. Sullivan JL, Woda BA. X-linked lymphoproliferative syndrome. Immunodefic Rev. 1989; 1(4):325-47.
    View in: PubMed
    Score: 0.005
  31. Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer. 2008 Dec 15; 113(12):3331-40.
    View in: PubMed
    Score: 0.005
  32. Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Mod Pathol. 2008 Nov; 21(11):1394-402.
    View in: PubMed
    Score: 0.005
  33. Jiang Z, Chu PG, Woda BA, Liu Q, Balaji KC, Rock KL, Wu CL. Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. Clin Cancer Res. 2008 Sep 01; 14(17):5579-84.
    View in: PubMed
    Score: 0.005
  34. Giassi LJ, Pearson T, Shultz LD, Laning J, Biber K, Kraus M, Woda BA, Schmidt MR, Woodland RT, Rossini AA, Greiner DL. Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice. Exp Biol Med (Maywood). 2008 Aug; 233(8):997-1012.
    View in: PubMed
    Score: 0.005
  35. Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA, Lu D. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2008 Jul; 17(7):1648-52.
    View in: PubMed
    Score: 0.005
  36. Sitnikova L, Mendese G, Liu Q, Woda BA, Lu D, Dresser K, Mohanty S, Rock KL, Jiang Z. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Clin Cancer Res. 2008 Mar 15; 14(6):1701-6.
    View in: PubMed
    Score: 0.005
  37. Hochberg JC, Miron PM, Hay BN, Woda BA, Wang SA, Richert-Przygonska M, Aprikyan AA, Newburger PE. Mosaic tetraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia. Pediatr Blood Cancer. 2008 Mar; 50(3):630-2.
    View in: PubMed
    Score: 0.005
  38. Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang SA. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Leuk Res. 2008 Apr; 32(4):553-8.
    View in: PubMed
    Score: 0.004
  39. Stachurski D, Smith BR, Pozdnyakova O, Andersen M, Xiao Z, Raza A, Woda BA, Wang SA. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res. 2008 Feb; 32(2):215-24.
    View in: PubMed
    Score: 0.004
  40. Stachurski D, Miron PM, Al-Homsi S, Hutchinson L, Harris NL, Woda B, Wang SA. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24. Hum Pathol. 2007 Jun; 38(6):940-5.
    View in: PubMed
    Score: 0.004
  41. Wang SA, Galili N, Cerny J, Sechman E, Chen SS, Loew J, Liu Q, Fadare O, Hasserjian R, Jones D, Qawi H, Woda B, Raza A. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. Am J Clin Pathol. 2006 Nov; 126(5):789-97.
    View in: PubMed
    Score: 0.004
  42. Sharma V, Andersen D, Thompson M, Woda BA, Stoff JS, Hartigan C, Rastellini C, Phillips D, Mordes JP, Rossini AA. Autoimmunity after islet-cell allotransplantation. N Engl J Med. 2006 09 28; 355(13):1397-9.
    View in: PubMed
    Score: 0.004
  43. Vanguri VK, Woda BA, Jiang Z. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies. Appl Immunohistochem Mol Morphol. 2006 Sep; 14(3):365-8.
    View in: PubMed
    Score: 0.004
  44. Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S, Liu Q, Zhao W, Mehdi M, Galili N, Woda B, Raza A. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia. 2006 Sep; 20(9):1641-4.
    View in: PubMed
    Score: 0.004
  45. Jiang Z, Chu PG, Woda BA, Rock KL, Liu Q, Hsieh CC, Li C, Chen W, Duan HO, McDougal S, Wu CL. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol. 2006 Jul; 7(7):556-64.
    View in: PubMed
    Score: 0.004
  46. Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006 Jul 01; 24(19):3121-7.
    View in: PubMed
    Score: 0.004
  47. Rezk S, Wheelock L, Fletcher JA, Oliveira AM, Keuker CP, Newburger PE, Xu B, Woda BA, Miron PM. Acute lymphocytic leukemia with eosinophilia and unusual karyotype. Leuk Lymphoma. 2006 Jun; 47(6):1176-9.
    View in: PubMed
    Score: 0.004
  48. Carswell BM, Woda BA, Wang X, Li C, Dresser K, Jiang Z. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy. Histopathology. 2006 May; 48(6):668-73.
    View in: PubMed
    Score: 0.004
  49. Ross RW, Halabi S, Ou SS, Rajeshkumar BR, Woda BA, Vogelzang NJ, Small EJ, Taplin ME, Kantoff PW. Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study. Clin Cancer Res. 2005 Nov 15; 11(22):8109-13.
    View in: PubMed
    Score: 0.004
  50. Mordes JP, Guberski DL, Leif JH, Woda BA, Flanagan JF, Greiner DL, Kislauskis EH, Tirabassi RS. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes. 2005 Sep; 54(9):2727-33.
    View in: PubMed
    Score: 0.004
  51. Daum GS, Liepman M, Woda BA. Dendritic cell phenotype in localized malignant histiocytosis of the small intestine. Arch Pathol Lab Med. 1985 Jul; 109(7):647-50.
    View in: PubMed
    Score: 0.004
  52. Badon SJ, Ansell J, Smith TW, Coslovsky R, Gill L, Woda BA. Diabetes insipidus caused by extramedullary hematopoiesis. Am J Clin Pathol. 1985 Apr; 83(4):509-12.
    View in: PubMed
    Score: 0.004
  53. Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD, Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology. 2004 Sep; 45(3):218-25.
    View in: PubMed
    Score: 0.004
  54. Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol. 2004 Aug; 35(8):1008-13.
    View in: PubMed
    Score: 0.004
  55. Jiang Z, Woda BA, Wu CL, Yang XJ. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Am J Clin Pathol. 2004 Aug; 122(2):275-89.
    View in: PubMed
    Score: 0.004
  56. Woda BA, Bain K, Vander Salm T. The phenotype of lymphocytes in a thymoma as studied with monoclonal antibodies. Clin Immunol Immunopathol. 1984 Feb; 30(2):197-201.
    View in: PubMed
    Score: 0.003
  57. Jiang Z, Iczkowski KA, Woda BA, Tretiakova M, Yang XJ. P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004 Jan; 121(1):99-107.
    View in: PubMed
    Score: 0.003
  58. Yang XJ, Laven B, Tretiakova M, Blute RD, Woda BA, Steinberg GD, Jiang Z. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma. Urology. 2003 Aug; 62(2):282-6.
    View in: PubMed
    Score: 0.003
  59. Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J, Chu PG. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases. Hum Pathol. 2003 Aug; 34(8):792-6.
    View in: PubMed
    Score: 0.003
  60. Taplin ME, Rajeshkumar B, Halabi S, Werner CP, Woda BA, Picus J, Stadler W, Hayes DF, Kantoff PW, Vogelzang NJ, Small EJ. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. J Clin Oncol. 2003 Jul 15; 21(14):2673-8.
    View in: PubMed
    Score: 0.003
  61. Jiang Z, Fanger GR, Banner BF, Woda BA, Algate P, Dresser K, Xu J, Reed SG, Rock KL, Chu PG. A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev. 2003; 27(6):422-6.
    View in: PubMed
    Score: 0.003
  62. Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR, Yang XJ. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002 Sep; 26(9):1169-74.
    View in: PubMed
    Score: 0.003
  63. Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002 Jul; 26(7):921-5.
    View in: PubMed
    Score: 0.003
  64. Jiang Z, Woda BA, Yang XJ. Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer. JAMA. 2002 Jun 19; 287(23):3080-1; author reply 3081.
    View in: PubMed
    Score: 0.003
  65. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P, Reed SG, Xu J, Fanger GR. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001 Nov; 25(11):1397-404.
    View in: PubMed
    Score: 0.003
  66. Woda BA, Yguerabide J, Feldman JD. Mobility of surface proteins on normal rat macrophages and on a "macrophagelike" rat tumor. J Cell Biol. 1981 Sep; 90(3):705-10.
    View in: PubMed
    Score: 0.003
  67. Moore BE, Banner BF, Gokden M, Woda B, Liu Y, Ayala A, Jiang Z. p53: a good diagnostic marker for intratubular germ cell neoplasia, unclassified. Appl Immunohistochem Mol Morphol. 2001 Sep; 9(3):203-6.
    View in: PubMed
    Score: 0.003
  68. Woda BA, Yguerabide J, Feldman JD. The effect of local anesthetics on the lateral mobility of lymphocyte membrane proteins. Exp Cell Res. 1980 Apr; 126(2):327-31.
    View in: PubMed
    Score: 0.003
  69. Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, Greiner DL. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood. 2000 Mar 15; 95(6):2175-82.
    View in: PubMed
    Score: 0.003
  70. Feldman JD, Woda BA. Pathology and tumor incidence in aged Lewis and BN rats. Clin Immunol Immunopathol. 1980 Mar; 15(3):331-43.
    View in: PubMed
    Score: 0.003
  71. Welsh RM, Markees TG, Woda BA, Daniels KA, Brehm MA, Mordes JP, Greiner DL, Rossini AA. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol. 2000 Mar; 74(5):2210-8.
    View in: PubMed
    Score: 0.003
  72. Woda BA, Yguerabide J, Feldman JD. Mobility and density of AgB, "Ia", and Fc receptors on the surface of lymphocytes from young and old rats. J Immunol. 1979 Nov; 123(5):2161-7.
    View in: PubMed
    Score: 0.003
  73. Cai YC, Jiang Z, Vittimberga F, Xu X, Savas L, Woda B, Callery M, Banner B. Expression of transforming growth factor-alpha and epidermal growth factor receptor in gastrointestinal stromal tumours. Virchows Arch. 1999 Aug; 435(2):112-5.
    View in: PubMed
    Score: 0.002
  74. Markees TG, Serreze DV, Phillips NE, Sorli CH, Gordon EJ, Shultz LD, Noelle RJ, Woda BA, Greiner DL, Mordes JP, Rossini AA. NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes. 1999 May; 48(5):967-74.
    View in: PubMed
    Score: 0.002
  75. Woda BA, Feldman JD. Density of surface immunoglobulin and capping on rat B lymphocytes. I. Changes with aging. J Exp Med. 1979 Feb 01; 149(2):416-23.
    View in: PubMed
    Score: 0.002
  76. Jiang Z, Woda BA, Savas L, Fraire AE. Expression of ICAM-1, VCAM-1, and LFA-1 in adenocarcinoma of the lung with observations on the expression of these adhesion molecules in non-neoplastic lung tissue. Mod Pathol. 1998 Dec; 11(12):1189-92.
    View in: PubMed
    Score: 0.002
  77. Dubin DB, Hurowitz JC, Brettler D, Bernhard JD, Kadin ME, Wallace JE, Woda B, Pihan G, Kupper TS, Harrist TJ. Adnexotropic T-cell lymphoma presenting with generalized anhidrosis, progressive alopecia, pruritus, and Sj?gren's syndrome. J Am Acad Dermatol. 1998 Mar; 38(3):493-7.
    View in: PubMed
    Score: 0.002
  78. Rao SK, Krishna M, Woda BA, Savas L, Fraire AE. Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular compartments of the lung. Mod Pathol. 1996 May; 9(5):555-9.
    View in: PubMed
    Score: 0.002
  79. Krishna M, Woda B, Savas L, Baker S, Banner B. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod Pathol. 1995 Aug; 8(6):654-7.
    View in: PubMed
    Score: 0.002
  80. Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol. 1995 Jul; 147(1):79-91.
    View in: PubMed
    Score: 0.002
  81. Szomolanyi-Tsuda E, Dundon PL, Joris I, Shultz LD, Woda BA, Welsh RM. Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice. Am J Pathol. 1994 Feb; 144(2):359-71.
    View in: PubMed
    Score: 0.002
  82. Maher VE, Gill L, Townes PL, Wallace JE, Savas L, Woda BA, Ansell JE. Simultaneous chronic lymphocytic leukemia and chronic myelogenous leukemia. Evidence of a separate stem cell origin. Cancer. 1993 Mar 15; 71(6):1993-7.
    View in: PubMed
    Score: 0.002
  83. Strongwater SL, Woda BA, Yood RA, Rybak ME, Sargent J, DeGirolami U, Smith TW, Varnis C, Allen S, Murphy K, et al. Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesis. Arch Intern Med. 1990 Oct; 150(10):2178-86.
    View in: PubMed
    Score: 0.001
  84. Boruchoff SE, Woda BA, Pihan GA, Durbin WA, Burstein D, Blacklow NR. Parvovirus B19-associated hemophagocytic syndrome. Arch Intern Med. 1990 Apr; 150(4):897-9.
    View in: PubMed
    Score: 0.001
  85. Ansell J, Badon S, Woda BA, Smith TW. Diabetes insipidus associated with dysplastic pancytopenia. Am J Med. 1987 Jul; 83(1):189.
    View in: PubMed
    Score: 0.001
  86. Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schweid A, Herzog P, Lange B, et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood. 1986 Nov; 68(5):1042-9.
    View in: PubMed
    Score: 0.001
  87. Forman SJ, Nathwani BN, Woda BA, Paladugu RR, Farbstein MJ. Clonal evolution of T-cell prolymphocytic leukemia to a T-large-cell lymphoma. A morphologic and immunologic study. Arch Pathol Lab Med. 1985 Dec; 109(12):1081-4.
    View in: PubMed
    Score: 0.001
  88. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C. Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood. 1985 May; 65(5):1097-104.
    View in: PubMed
    Score: 0.001
  89. Ryan PJ, Davis MA, DeGaeta LR, Woda B, Melchior DL. Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress. Radiology. 1984 Sep; 152(3):759-62.
    View in: PubMed
    Score: 0.001
  90. Rossini AA, Slavin S, Woda BA, Geisberg M, Like AA, Mordes JP. Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes. 1984 Jun; 33(6):543-7.
    View in: PubMed
    Score: 0.001
  91. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol. 1983 Sep; 131(3):1531-8.
    View in: PubMed
    Score: 0.001
  92. Gilman SC, Woda BA, Feldman JD. T lymphocytes of young and aged rats. I. Distribution, density, and capping of T antigens. J Immunol. 1981 Jul; 127(1):149-53.
    View in: PubMed
    Score: 0.001
  93. Appel GB, Woda BA, Neu HC, Parry MF, Silva F, Pirani CL. Acute interstitial nephritis associated with carbenicillin therapy. Arch Intern Med. 1978 Aug; 138(8):1265-7.
    View in: PubMed
    Score: 0.001
  94. Pertschuk LP, Woda BA, Vuletin JC, Brigati DJ, Soriano CB, Nicastri AD. Glomerulonephritis due to Staphylococcus aureus antigen. Am J Clin Pathol. 1976 Mar; 65(3):301-7.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.